vs
Blue Foundry Bancorp（BLFY）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Blue Foundry Bancorp的1.5倍（$19.6M vs $13.3M），Blue Foundry Bancorp净利率更高（-27.4% vs -177.4%，领先150.0%），Blue Foundry Bancorp同比增速更快（34.2% vs -11.5%），过去两年Blue Foundry Bancorp的营收复合增速更高（16.0% vs -12.2%）
Blue Foundry Bancorp是总部位于美国新泽西州的区域银行控股公司，主要面向当地个人消费者与中小企业，提供存款账户、消费贷款、住房按揭、商业融资等全方位的个人及商业银行服务。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
BLFY vs LAB — 直观对比
营收规模更大
LAB
是对方的1.5倍
$13.3M
营收增速更快
BLFY
高出45.7%
-11.5%
净利率更高
BLFY
高出150.0%
-177.4%
两年增速更快
BLFY
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.3M | $19.6M |
| 净利润 | $-3.5M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | -27.4% | -177.4% |
| 营收同比 | 34.2% | -11.5% |
| 净利润同比 | -30.6% | -28.8% |
| 每股收益（稀释后） | $-0.18 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFYLAB
| Q4 25 | $13.3M | — | ||
| Q3 25 | $12.6M | $19.6M | ||
| Q2 25 | $12.0M | $21.8M | ||
| Q1 25 | $11.1M | $40.8M | ||
| Q4 24 | $9.9M | — | ||
| Q3 24 | $9.5M | $22.1M | ||
| Q2 24 | $10.1M | $22.5M | ||
| Q1 24 | $9.9M | $45.5M |
净利润BLFYLAB
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-1.9M | $-34.7M | ||
| Q2 25 | $-2.0M | $-33.5M | ||
| Q1 25 | $-2.7M | $-26.0M | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-4.0M | $-26.9M | ||
| Q2 24 | $-2.3M | $-45.7M | ||
| Q1 24 | $-2.8M | $-32.2M |
毛利率BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -168.5% | ||
| Q2 25 | — | -118.1% | ||
| Q1 25 | — | -80.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | — | -132.2% |
净利率BLFYLAB
| Q4 25 | -27.4% | — | ||
| Q3 25 | -14.8% | -177.4% | ||
| Q2 25 | -16.2% | -153.7% | ||
| Q1 25 | -24.2% | -63.8% | ||
| Q4 24 | -28.4% | — | ||
| Q3 24 | -42.7% | -122.0% | ||
| Q2 24 | -23.2% | -203.3% | ||
| Q1 24 | -28.8% | -70.6% |
每股收益（稀释后）BLFYLAB
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.10 | $-0.09 | ||
| Q2 25 | $-0.10 | $-0.09 | ||
| Q1 25 | $-0.13 | $-0.07 | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.19 | $-0.07 | ||
| Q2 24 | $-0.11 | $-0.12 | ||
| Q1 24 | $-0.13 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.1M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $312.7M | $399.7M |
| 总资产 | $2.2B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BLFYLAB
| Q4 25 | $53.1M | — | ||
| Q3 25 | $44.1M | $129.4M | ||
| Q2 25 | $41.9M | $158.6M | ||
| Q1 25 | $46.2M | $150.9M | ||
| Q4 24 | $42.5M | — | ||
| Q3 24 | $76.1M | $210.6M | ||
| Q2 24 | $60.3M | $269.8M | ||
| Q1 24 | $53.8M | $287.1M |
总债务BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益BLFYLAB
| Q4 25 | $312.7M | — | ||
| Q3 25 | $314.4M | $399.7M | ||
| Q2 25 | $321.3M | $424.5M | ||
| Q1 25 | $326.7M | $454.6M | ||
| Q4 24 | $332.2M | — | ||
| Q3 24 | $339.3M | $489.3M | ||
| Q2 24 | $345.6M | $510.3M | ||
| Q1 24 | $350.2M | $577.3M |
总资产BLFYLAB
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $539.6M | ||
| Q2 25 | $2.1B | $557.0M | ||
| Q1 25 | $2.1B | $579.6M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $681.5M | ||
| Q2 24 | $2.0B | $708.7M | ||
| Q1 24 | $2.0B | $777.7M |
负债/权益比BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流BLFYLAB
| Q4 25 | $-8.0M | — | ||
| Q3 25 | $-255.0K | $-22.2M | ||
| Q2 25 | $2.0M | $-20.7M | ||
| Q1 25 | $-3.8M | $-30.3M | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $-3.7M | $-27.9M | ||
| Q2 24 | $14.1M | $-39.0M | ||
| Q1 24 | $-4.9M | $-62.5M |
自由现金流BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | $-4.9M | $-63.3M |
自由现金流率BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | 49.8% | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | -49.3% | -138.9% |
资本支出强度BLFYLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | 0.1% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLFY
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
